Business Context and Reporting Period
This Form 8-K Current Report was filed by Zimmer Biomet Holdings, Inc. on October 29, 2021. The filing addresses a change in the Company's senior financial leadership under Item 5.02.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change disclosed is the departure of Carrie Nichol, Vice President, Controller, and Chief Accounting Officer, effective November 26, 2021. The Company explicitly states that her departure is not the result of any disagreement regarding financial reporting, accounting policies, procedures, estimates, or judgments.
Outlook, Management Commentary, and Risks
Management has appointed Derek Davis, currently the Vice President, Finance Integration, to serve as the Interim Controller and Chief Accounting Officer effective November 26, 2021. Mr. Davis previously held the Controller and Chief Accounting Officer roles from 2007 to 2015. The Company will initiate a search for a permanent replacement. No other risks, contingencies, or unusual items are disclosed in this filing.
Investor Verification Checklist
- Confirm the effective date of the leadership transition (November 26, 2021).
- Verify the background and tenure of the interim appointee, Derek Davis.
- Monitor future filings for the appointment of a permanent Chief Accounting Officer.
- Note that this filing contains no financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.